TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›BMEA›Financials
Annual statements · SEC XBRL · FY2019 – FY2025

Biomea Fusion, Inc. (BMEA) financials

Income statement

Biomea Fusion, Inc. (BMEA) income statement, annual, from SEC filings
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income-$1.20M-$5.33M-$41.7M-$83.6M-$126M-$144M-$83.5M
Net income-$1.20M-$5.32M-$41.6M-$81.8M-$117M-$138M-$61.8M
EPS (diluted)-$0.20-$0.51-$1.74-$2.80-$3.44-$3.83-$1.18

Cash flow

Biomea Fusion, Inc. (BMEA) cash flow, annual, from SEC filings
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$1.28M-$4.46M-$35.4M-$62.4M-$96.6M-$120M-$70.4M
Capital expenditures—$51.0K$3.17M$1.03M$3.37M$362K—
Free cash flow—-$4.51M-$38.6M-$63.4M-$100.0M-$120M—

Balance sheet

Biomea Fusion, Inc. (BMEA) balance sheet, annual, from SEC filings
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$239K$61.7M$146M$112M$177M$58.3M$55.8M
Total assets—$62.5M$186M$129M$200M$79.9M$58.6M
Total liabilities—$1.62M$6.92M$20.8M$30.7M$28.4M$29.0M
Shareholders' equity-$21.0K$5.17M$179M$109M$169M$51.6M$29.6M
Retained earnings—-$8.18M-$49.7M-$132M-$249M-$387M-$449M
Shares (wtd avg diluted)—10.5M23.9M29.3M34.1M36.1M52.2M

Every figure is extracted from Biomea Fusion, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

Does BMEA pay a dividend?
Biomea Fusion, Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full BMEA analysis — verdict, score & filings →Is BMEA a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.